Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent RE41289 Ultrashort acting hypnotic barbiturates

Patent RE41289 was granted and assigned to Aryx Therapeutics on April, 2010 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 30 Oct, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 30 Oct, 2023
Edits made to:
Article (+345 characters)
Article

Patent abstract

The subject invention concerns novel compounds that are useful as ultrashort acting hypnotic barbiturates. Specifically exemplified are derivatives of barbituric and thiobarbituric acids. They are rapidly metabolized by blood and tissue enzymes to form polar metabolites with no hypnotic activity and which are rapidly eliminated.

Edits on 18 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 18 Sep, 2023
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Pascal Druzgala0
Peter G. Milner0
Edits on 23 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 23 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent RE041289 Ultrashort acting hypnotic barbiturates US Patent RE41289 Ultrashort acting hypnotic barbiturates

Infobox
Patent Number
RE04128900
Patent Number
RE4128900
Edits on 20 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 20 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=RE04128900
Edits on 23 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 23 Apr, 2023
Infobox
Is a
Patent
Patent
0
Current Assignee
Aryx Therapeutics
Aryx Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
RE0412890
Date of Patent
April 27, 2010
0
Patent Application Number
120094460
Date Filed
December 20, 2007
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=RE0412890
Patent Primary Examiner
‌
Venkataraman Balasubramanian
0
Edits on 23 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
Infobox
Is a
Patent
Patent
0
Current Assignee
Aryx Therapeutics
Aryx Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
RE0412890
Date of Patent
April 27, 2010
0
Patent Application Number
120094460
Date Filed
December 20, 2007
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=RE0412890
Patent Primary Examiner
‌
Venkataraman Balasubramanian
0
Edits on 18 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 18 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=RE041289
Edits on 4 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 4 Dec, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent RE041289 Ultrashort acting hypnotic barbiturates

Infobox
Is a
Patent
Patent
Current assignee
Aryx Therapeutics
Aryx Therapeutics
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
RE041289
Date of patent
April 27, 2010
Patent application number
12009446
Date Filed
December 20, 2007
Patent primary examiner
‌
Venkataraman Balasubramanian

Find more entities like US Patent RE41289 Ultrashort acting hypnotic barbiturates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.